Regencell Bioscience (RGC) has had the highest return since March 20, 2024 by a mid-cap US stock, returning 14,436.3%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 14,436.27% |
Power Solutions International, Inc Common Stock (PSIX) | 4,168.52% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 3,880% |
Quantum Computing (QUBT) | 1,521.37% |
GeneDx (WGS) | 1,256.94% |
Innodata (INOD) | 1,205.23% |
Eos Energy Enterprises (EOSE) | 1,137% |
CommScope (COMM) | 1,084.44% |
D-Wave Quantum (QBTS) | 1,065% |
Uniqure (QURE) | 969.84% |
Centrus Energy (LEU) | 733.19% |
Sezzle (SEZL) | 668.44% |
Ondas (ONDS) | 645.92% |
Mesoblast (MESO) | 616.74% |
Verona Pharma PLC ADR (VRNA) | 598.17% |
Cidara Therapeutics (CDTX) | 572.2% |
Terawulf (WULF) | 570.76% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 563.88% |
SSR Mining (SSRM) | 497.25% |
Dave (DAVE) | 496.94% |
Planet Labs PBC (PL) | 488.46% |
Applied Digital (APLD) | 481.4% |
Argan (AGX) | 470.05% |
VNET Group Inc DRC (VNET) | 466.32% |
Abivax SA American Depositary Shares (ABVX) | 465.16% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
